These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2749939)

  • 21. Calcium oxalate crystallization kinetics studied by oxalate-induced turbidity in fresh human urine and artificial urine.
    Kavanagh JP; Jones L; Rao PN
    Clin Sci (Lond); 2000 Feb; 98(2):151-8. PubMed ID: 10657269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calcium oxalate lithiasis. Relationship between biochemical risk factors and crystalline phase of the stone].
    Parent X; Boess G; Brignon P
    Prog Urol; 1999 Dec; 9(6):1051-6. PubMed ID: 10658250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Crystalline urinary sediment and its diagnostic significance in lithiasis].
    Berg W; Bothor C; Szabo-Földvari E; Schneider HJ
    Arch Esp Urol; 1982; 35(6):389-401. PubMed ID: 7165404
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Urine saturation with calcium oxalate in urolithiasis].
    Bogado CE; Zanchetta JR
    Medicina (B Aires); 1988; 48(1):39-44. PubMed ID: 3216787
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rhythm of diurnal and seasonal urine excretion in calcium oxalate-urinary calculi patients and healthy humans and its effect on the incidence of calculi].
    Schulz E; Brundig P; Pirlich W
    Urologe A; 1984 Mar; 23(2):77-81. PubMed ID: 6539024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium oxalate crystal growth. A new constant composition method for modelling urinary stone formation.
    Sheehan ME; Nancollas GH
    Invest Urol; 1980 May; 17(6):446-50. PubMed ID: 7372431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nucleation and growth kinetics of calcium oxalate in the presence of some synthetic urine constituents.
    Rodgers AL; Garside J
    Invest Urol; 1981 May; 18(8):484-8. PubMed ID: 7228583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Morphological typing of calcium oxalate calculi and etiopathogenic findings].
    Daudon M; Reveillaud RJ
    Ann Urol (Paris); 1985; 19(5):299-308. PubMed ID: 4083837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium oxalate crystalluria in a goat.
    Clark P; Swenson CL; Osborne CA; Ulrich LK
    J Am Vet Med Assoc; 1999 Jul; 215(1):77-8. PubMed ID: 10397070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Indicators of the risk of calcium oxalate urinary calculi: comparative study of the Parks' and Tiselius' indices, urinary citrate/calciuria ratio, and morning crystalluria].
    Robert M; Boularan AM; Guiter J; Monnier L
    Prog Urol; 1996 Apr; 6(2):264-8. PubMed ID: 8777421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium oxalate crystallization in urine of healthy men and women: a comparative study.
    Buchholz NP; Kim DS; Grover PK; Ryall RL
    Scanning Microsc; 1996; 10(2):435-42; discussion 442-4. PubMed ID: 9813622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of chorei-to and gorei-san on calcium oxalate crystallization in human urine].
    Yoshimura K; Miyake O; Okuyama A; Yoshioka T; Honda M; Yamaguchi S; Koide T
    Hinyokika Kiyo; 1998 Jan; 44(1):13-6. PubMed ID: 9503201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and metabolic aspects of urinary stone disease in Leeds.
    Robertson WG; Peacock M; Heyburn PJ
    Scand J Urol Nephrol Suppl; 1980; 53():199-206. PubMed ID: 7010570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can the formation of calcium oxalate stones be explained by crystallization processes in urine?
    Baumann JM
    Urol Res; 1985; 13(6):267-70. PubMed ID: 3913100
    [No Abstract]   [Full Text] [Related]  

  • 36. Physico-chemical aspects of calcium stone formation.
    Baumann JM
    Urol Res; 1990; 18 Suppl 1():S25-30. PubMed ID: 1963243
    [No Abstract]   [Full Text] [Related]  

  • 37. How reliable are the measurements of crystallization conditions in urine?
    Baumann JM
    Urol Res; 1988; 16(3):133-5. PubMed ID: 3413904
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of a variable differential function on the stone-growth-related urinary depletion effect.
    Pullmann M; Hergarten S; Laube N
    Clin Chem; 2004 Sep; 50(9):1675-8. PubMed ID: 15331506
    [No Abstract]   [Full Text] [Related]  

  • 39. [Urinary low molecular promoter of calcium oxalate monohydrate crystal aggregation, preliminary report].
    Shirane Y; Hiraishi K; Kurokawa K
    Nihon Hinyokika Gakkai Zasshi; 1987 Jul; 78(7):1149-54. PubMed ID: 3682505
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibitory effects of urinary calcium-binding substances on calcium oxalate crystallization.
    Resnick MI; Sorrell ME; Bailey JA; Boyce WH
    J Urol; 1982 Mar; 127(3):568-71. PubMed ID: 7062442
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.